top of page

The TRanslational Initiative to DE-Risk Therapeutics

This Just In! HQP Spotlight on Aya Arrar, PhD Candidate of the TRIDENT Mouse Core (Western University). Check out the full interview HERE!

Revolutionary
Preclinical
Evaluation.

F3BBVLoaYAEUrB9.jpg

 

The TRanslational Initiative to ​DErisk NeuroTherapeutic (TRIDENT) draws upon research supported by the Government of Canada’s New Frontiers in Research Fund (NFRF).
 

Le TRanslational Initiative to ​DErisk NeuroTherapeutic (TRIDENT) repose sur des recherches financées par le fonds Nouvelles frontières en recherche dugouvernement du Canada.


By offering a transformative approach to preclinical evaluation of neurotherapeutics, TRIDENT will dramatically improve the odds of success of  neurotherapeutics in clinical trials for the benefit of humans across the globe.

One Platform.
3 Integrated Model Systems.

bottom of page